Anderson DJ (1989) Determination of the lower limit of detection. Clin Chem 35:2152–2153
CAS
PubMed
Google Scholar
Bakkar N, Boehringer A, Bowser R (2015) Use of biomarkers in ALS drug development and clinical trials. Brain Res 1607:94–107. https://doi.org/10.1016/j.brainres.2014.10.031
CAS
Article
PubMed
Google Scholar
Bishop P, Rocca D, Henley JM (2016) Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J 473:2453–2462. https://doi.org/10.1042/BCJ20160082
CAS
Article
PubMed
PubMed Central
Google Scholar
Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, the NFLG, Alvarez-Cermeno JC, Andreasson U, Axelsson M, Backstrom DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialova L, Forsgren L, Frederiksen JL, Gisslen M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landen M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Perez-Santiago J, Piehl F, Pijnenburg YAL, Pyykko OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillback T, Stilund M, Sundstrom P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vagberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelso C, Wild EJ (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.1534
Article
Google Scholar
Choi YS, Hou S, Choe LH, Lee KH (2013) Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates. J Chromatogr B Anal Technol Biomed Life Sci 930:129–135. https://doi.org/10.1016/j.jchromb.2013.05.003
CAS
Article
Google Scholar
Constantinescu R, Andreasson U, Li S, Podust VN, Mattsson N, Anckarsater R, Anckarsater H, Rosengren L, Holmberg B, Blennow K, Wikkelso C, Ruetschi U, Zetterberg H (2010) Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord 16:545–549. https://doi.org/10.1016/j.parkreldis.2010.06.011
Article
PubMed
Google Scholar
Davison EJ, Pennington K, Hung CC, Peng J, Rafiq R, Ostareck-Lederer A, Ostareck DH, Ardley HC, Banks RE, Robinson PA (2009) Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. Proteomics 9:4284–4297. https://doi.org/10.1002/pmic.200900126
CAS
Article
PubMed
Google Scholar
Diaz-Vera J, Morales YG, Hernandez-Fernaud JR, Camacho M, Montesinos MS, Calegari F, Huttner WB, Borges R, Machado JD (2010) Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles. J Neurosci 30:950–957. https://doi.org/10.1523/JNEUROSCI.2894-09.2010
CAS
Article
PubMed
PubMed Central
Google Scholar
Dos Santos MCT, Scheller D, Schulte C, Mesa IR, Colman P, Bujac SR, Bell R, Berteau C, Perez LT, Lachmann I, Berg D, Maetzler W, Nogueira da Costa A (2018) Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis. PLoS One 13:e0206536. https://doi.org/10.1371/journal.pone.0206536
CAS
Article
PubMed
Google Scholar
Ebhardt HA, Root A, Sander C, Aebersold R (2015) Applications of targeted proteomics in systems biology and translational medicine. Proteomics 15:3193–3208. https://doi.org/10.1002/pmic.201500004
CAS
Article
PubMed
PubMed Central
Google Scholar
EFNS task force on diagnosis and management of ALS, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 19:360–375. https://doi.org/10.1111/j.1468-1331.2011.03501.x
Eriksson L, Trygg J, Wold S (2008) CV-ANOVA for significance testing of PLS and OPLS (R) models. J Chemom 22:594–600. https://doi.org/10.1002/cem.1187
CAS
Article
Google Scholar
Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Bruhmann J, Brandt R, Christine CW, Aminoff MJ, Hellerstein MK (2012) Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest 122:3159–3169. https://doi.org/10.1172/JCI64575
CAS
Article
PubMed
PubMed Central
Google Scholar
Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T (2010) Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One 5:e11552. https://doi.org/10.1371/journal.pone.0011552
CAS
Article
PubMed
PubMed Central
Google Scholar
Forsberg K, Andersen PM, Marklund SL, Brannstrom T (2011) Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 121:623–634. https://doi.org/10.1007/s00401-011-0805-3
CAS
Article
PubMed
PubMed Central
Google Scholar
Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, Brannstrom T, Andersen PM (2019) Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry 90:861–869. https://doi.org/10.1136/jnnp-2018-319386
Article
PubMed
PubMed Central
Google Scholar
Forsgren L, Almay BG, Holmgren G, Wall S (1983) Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 68:20–29
CAS
Article
Google Scholar
Gabriel TL, Tol MJ, Ottenhof R, van Roomen C, Aten J, Claessen N, Hooibrink B, de Weijer B, Serlie MJ, Argmann C, van Elsenburg L, Aerts JM, van Eijk M (2014) Lysosomal stress in obese adipose tissue macrophages contributes to MITF-dependent Gpnmb induction. Diabetes 63:3310–3323. https://doi.org/10.2337/db13-1720
CAS
Article
PubMed
Google Scholar
Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Ozdinler PH (2016) Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum Mol Genet 25:1074–1087. https://doi.org/10.1093/hmg/ddv631
CAS
Article
PubMed
PubMed Central
Google Scholar
Genc B, Lagrimas AK, Kuru P, Hess R, Tu MW, Menichella DM, Miller RJ, Paller AS, Ozdinler PH (2015) Visualization of sensory neurons and their projections in an upper motor neuron reporter line. PLoS One 10:e0132815. https://doi.org/10.1371/journal.pone.0132815
CAS
Article
PubMed
PubMed Central
Google Scholar
Gibson SB, Kasarskis EJ, Hu N, Pulst SM, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, Kryscio RJ, Bromberg MB (2015) Relationship of creatine kinase to body composition, disease state, and longevity in ALS. Amyotroph Lateral Scler Frontotemporal Degener 16:473–477. https://doi.org/10.3109/21678421.2015.1062516
CAS
Article
PubMed
PubMed Central
Google Scholar
Gong Z, Gao L, Guo J, Lu Y, Zang D (2015) bFGF in the CSF and serum of sALS patients. Acta Neurol Scand 132:171–178. https://doi.org/10.1111/ane.12381
CAS
Article
PubMed
Google Scholar
Gros-Louis F, Andersen PM, Dupre N, Urushitani M, Dion P, Souchon F, D'Amour M, Camu W, Meininger V, Bouchard JP, Rouleau GA, Julien JP (2009) Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 106:21777–21782. https://doi.org/10.1073/pnas.0902174106
Article
PubMed
PubMed Central
Google Scholar
Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, Carecchio M, Reid E, Heslegrave A, Fenoglio C, Scarpini E, Schott JM, Fox NC, Hardy J, Bahtia K, Heales S, Sebire NJ, Zetterburg H, Mills K (2015) Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener 10:64. https://doi.org/10.1186/s13024-015-0059-y
CAS
Article
PubMed
PubMed Central
Google Scholar
World Medical Association (2013) Declaration of Helsinki, www.wma.net
Hsu SH, Lai MC, Er TK, Yang SN, Hung CH, Tsai HH, Lin YC, Chang JG, Lo YC, Jong YJ (2010) Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts. Clin Chim Acta 411:1920–1928. https://doi.org/10.1016/j.cca.2010.07.035
CAS
Article
PubMed
Google Scholar
Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grodem J, Corvol JC, Pihlstrom L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA (2019) Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. Neurol Genet 5:e348. https://doi.org/10.1212/NXG.0000000000000348
CAS
Article
PubMed
PubMed Central
Google Scholar
Jara JH, Genc B, Cox GA, Bohn MC, Roos RP, Macklis JD, Ulupinar E, Ozdinler PH (2015) Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function. Cereb Cortex 25:4259–4272. https://doi.org/10.1093/cercor/bhu318
Article
PubMed
PubMed Central
Google Scholar
Jonsson P, Wuolikainen A, Thysell E, Chorell E, Stattin P, Wikstrom P, Antti H (2015) Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. Metabolomics 11:1667–1678. https://doi.org/10.1007/s11306-015-0818-3
CAS
Article
PubMed
PubMed Central
Google Scholar
Konya C, Hatanaka Y, Fujiwara Y, Uchida K, Nagai Y, Wada K, Kabuta T (2011) Parkinson's disease-associated mutations in alpha-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1. Neurochem Int 59:251–258. https://doi.org/10.1016/j.neuint.2011.05.012
CAS
Article
PubMed
Google Scholar
Kuhn E, Wu J, Karl J, Liao H, Zolg W, Guild B (2004) Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 4:1175–1186. https://doi.org/10.1002/pmic.200300670
CAS
Article
PubMed
Google Scholar
van der Lienden MJC, Gaspar P, Boot R, Aerts J, van Eijk M (2018) Glycoprotein non-metastatic protein B: an emerging biomarker for lysosomal dysfunction in macrophages. Int J Mol Sci 20. https://doi.org/10.3390/ijms20010066
Article
Google Scholar
Liu Z, Meray RK, Grammatopoulos TN, Fredenburg RA, Cookson MR, Liu Y, Logan T, Lansbury PT Jr (2009) Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Proc Natl Acad Sci U S A 106:4635–4640. https://doi.org/10.1073/pnas.0806474106
Article
PubMed
PubMed Central
Google Scholar
Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A (2015) Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84:2247–2257. https://doi.org/10.1212/WNL.0000000000001642
CAS
Article
PubMed
PubMed Central
Google Scholar
Marques AR, Gabriel TL, Aten J, van Roomen CP, Ottenhoff R, Claessen N, Alfonso P, Irun P, Giraldo P, Aerts JM, van Eijk M (2016) Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease. PLoS One 11:e0147208. https://doi.org/10.1371/journal.pone.0147208
CAS
Article
PubMed
PubMed Central
Google Scholar
Mattsson N, Johansson P, Hansson O, Wallin A, Johansson JO, Andreasson U, Andersen O, Haghighi S, Olsson M, Stridsberg M, Svensson J, Blennow K, Zetterberg H (2010) Converging pathways of chromogranin and amyloid metabolism in the brain. J Alzheimers Dis 20:1039–1049. https://doi.org/10.3233/JAD-2010-091651
CAS
Article
PubMed
Google Scholar
McKeon JE, Sha D, Li L, Chin LS (2015) Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. Cell Mol Life Sci 72:1811–1824. https://doi.org/10.1007/s00018-014-1781-2
CAS
Article
PubMed
Google Scholar
Moloney EB, Moskites A, Ferrari EJ, Isacson O, Hallett PJ (2018) The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress. Neurobiol Dis 120:1–11. https://doi.org/10.1016/j.nbd.2018.08.013
CAS
Article
PubMed
Google Scholar
Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A (2014) CSF alpha-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders. Parkinsonism Relat Disord 20:382–387. https://doi.org/10.1016/j.parkreldis.2014.01.011
Article
PubMed
Google Scholar
Nagahara Y, Shimazawa M, Tanaka H, Ono Y, Noda Y, Ohuchi K, Tsuruma K, Katsuno M, Sobue G, Hara H (2015) Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neurosci Res 93:1552–1566. https://doi.org/10.1002/jnr.23619
CAS
Article
PubMed
Google Scholar
Neal ML, Boyle AM, Budge KM, Safadi FF, Richardson JR (2018) The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. J Neuroinflammation 15:73. https://doi.org/10.1186/s12974-018-1100-1
CAS
Article
PubMed
PubMed Central
Google Scholar
Offen D, Barhum Y, Melamed E, Embacher N, Schindler C, Ransmayr G (2009) Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci 38:85–93. https://doi.org/10.1007/s12031-007-9004-z
CAS
Article
PubMed
Google Scholar
Ohta Y, Soucy G, Phaneuf D, Audet JN, Gros-Louis F, Rouleau GA, Blasco H, Corcia P, Andersen PM, Nordin F, Yamashita T, Abe K, Julien JP (2016) Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. Hum Mol Genet. https://doi.org/10.1093/hmg/ddw304
Pal R, Alves G, Larsen JP, Moller SG (2014) New insight into neurodegeneration: the role of proteomics. Mol Neurobiol 49:1181–1199. https://doi.org/10.1007/s12035-013-8590-8
CAS
Article
PubMed
Google Scholar
Park DW, Nam MK, Rhim H (2011) The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death. Biochem Biophys Res Commun 415:24–29. https://doi.org/10.1016/j.bbrc.2011.09.148
CAS
Article
PubMed
Google Scholar
Percy AJ, Chambers AG, Yang JC, Domanski D, Borchers CH (2012) Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins. Anal Bioanal Chem 404:1089–1101. https://doi.org/10.1007/s00216-012-6010-y
CAS
Article
PubMed
Google Scholar
Percy AJ, Yang J, Chambers AG, Simon R, Hardie DB, Borchers CH (2014) Multiplexed MRM with internal standards for cerebrospinal fluid candidate protein biomarker quantitation. J Proteome Res. https://doi.org/10.1021/pr500317d
CAS
Article
Google Scholar
Powis RA, Mutsaers CA, Wishart TM, Hunter G, Wirth B, Gillingwater TH (2014) Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target. Neuropathol Appl Neurobiol 40:873–887. https://doi.org/10.1111/nan.12168
CAS
Article
PubMed
Google Scholar
Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM (2010) ADAM10 releases a soluble form of the GPNMB/osteoactivin extracellular domain with angiogenic properties. PLoS One 5:e12093. https://doi.org/10.1371/journal.pone.0012093
CAS
Article
PubMed
PubMed Central
Google Scholar
Schuur M, Ikram MA, van Swieten JC, Isaacs A, Vergeer-Drop JM, Hofman A, Oostra BA, Breteler MM, van Duijn CM (2011) Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta-analysis. Neurobiol Aging 32:1607–1614. https://doi.org/10.1016/j.neurobiolaging.2009.10.011
CAS
Article
PubMed
Google Scholar
Siebert M, Sidransky E, Westbroek W (2014) Glucocerebrosidase is shaking up the synucleinopathies. Brain 137:1304–1322. https://doi.org/10.1093/brain/awu002
Article
PubMed
PubMed Central
Google Scholar
Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, Tyynela J (2006) Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129:1438–1445. https://doi.org/10.1093/brain/awl107
Article
PubMed
Google Scholar
Tanaka H, Shimazawa M, Kimura M, Takata M, Tsuruma K, Yamada M, Takahashi H, Hozumi I, Niwa J, Iguchi Y, Nikawa T, Sobue G, Inuzuka T, Hara H (2012) The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep 2:573. https://doi.org/10.1038/srep00573
CAS
Article
PubMed
PubMed Central
Google Scholar
Trygg J, Wold S (2002) Orthogonal projections to latent structures (O-PLS). J Chemom 16:119–128. https://doi.org/10.1002/cem.695
CAS
Article
Google Scholar
Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9:108–118. https://doi.org/10.1038/nn1603
CAS
Article
PubMed
Google Scholar
Weis J, Katona I, Muller-Newen G, Sommer C, Necula G, Hendrich C, Ludolph AC, Sperfeld AD (2011) Small-fiber neuropathy in patients with ALS. Neurology 76:2024–2029. https://doi.org/10.1212/WNL.0b013e31821e553a
CAS
Article
PubMed
Google Scholar
Wold S, Esbensen K, Geladi P (1987) Principal component analysis. Chemom Intell Lab Syst 2:37–52. https://doi.org/10.1016/0169-7439(87)80084-9
CAS
Article
Google Scholar
Wu JF, Wuolikainen A, Trupp M, Jonsson P, Marklund SL, Andersen PM, Forsgren L, Ohman A (2016) NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Metabolomics 12:101. https://doi.org/10.1007/S11306-016-1041-6
Article
Google Scholar
Wuolikainen A, Jonsson P, Ahnlund M, Antti H, Marklund SL, Moritz T, Forsgren L, Andersen PM, Trupp M (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Mol BioSyst. https://doi.org/10.1039/c5mb00711a
CAS
Article
Google Scholar
Xi J, Yang X, Zhao Q, Zheng J, An R, Tian S, Huang H, Hu F, Ning P, Xu Y (2018) Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population. Neurosci Lett 662:181–184. https://doi.org/10.1016/j.neulet.2017.09.029
CAS
Article
PubMed
Google Scholar
Yang H, Zhou T, Wang H, Liu T, Ueda K, Zhan R, Zhao L, Tong Y, Tian X, Zhang T, Jin Y, Han X, Li Z, Zhao Y, Guo X, Xiao W, Fan D, Liu G, Chui D (2015a) Lipoprotein lipase deficiency leads to alpha-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction. Neuroscience 290:1–10. https://doi.org/10.1016/j.neuroscience.2014.12.068
CAS
Article
PubMed
Google Scholar
Yang X, Gao L, Wu X, Zhang Y, Zang D (2015b) Increased levels of MIP-1alpha in CSF and serum of ALS. Acta Neurol Scand. https://doi.org/10.1111/ane.12513
Article
Google Scholar
Yang CF, Lin SP, Chiang CP, Wu YH, H'Ng WS, Chang CP, Chen YT, Wu JY (2018) Loss of GPNMB causes autosomal-recessive amyloidosis cutis dyschromica in humans. Am J Hum Genet 102:219–232. https://doi.org/10.1016/j.ajhg.2017.12.012
CAS
Article
PubMed
PubMed Central
Google Scholar
Zigdon H, Savidor A, Levin Y, Meshcheriakova A, Schiffmann R, Futerman AH (2015) Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease. PLoS One 10:e0120194. https://doi.org/10.1371/journal.pone.0120194
CAS
Article
PubMed
PubMed Central
Google Scholar